» Articles » PMID: 32649009

Circulating Exosomal Long Non-coding RNAs in Patients with Acute Myocardial Infarction

Overview
Journal J Cell Mol Med
Date 2020 Jul 11
PMID 32649009
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are attracting considerable interest in the cardiovascular field as the wide range of their functions is recognized in acute myocardial infarction (AMI). However, the regulatory role of exosomal long non-coding RNAs (lncRNAs) in AMI remains largely unclear. Exosomes were isolated from the plasma of AMI patients and controls, and the sequencing profiles and twice qRT-PCR validations of exosomal lncRNAs were performed. A total of 518 differentially expressed lncRNAs were detected over two-fold change, and 6 kinds of lncRNAs were strikingly elevated in AMI patients with top fold change and were selected to perform subsequent validation. In the two validations, lncRNAs ENST00000556899.1 and ENST00000575985.1 were significantly up-regulated in AMI patients compared with controls. ROC curve analysis revealed that circulating exosomal lncRNAs ENST00000556899.1 and ENST00000575985.1 yielded the area under the curve values of 0.661 and 0.751 for AMI, respectively. Moreover, ENST00000575985.1 showed more significant relationship with clinical parameters, including inflammatory biomarkers, prognostic indicators and myocardial damage markers. Multivariate logistic model exhibited positive association of ENST00000575985.1 with the risk of heart failure in AMI patients. In summary, our data demonstrated that circulating exosomal lncRNAs ENST00000556899.1 and ENST00000575985.1 are elevated in patients with AMI, functioning as potential biomarkers for predicting the prognosis of pateints with AMI.

Citing Articles

The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation.

Celeski M, Segreti A, Crisci F, Cricco R, Piscione M, Di Gioia G Biomolecules. 2025; 14(12.

PMID: 39766337 PMC: 11727179. DOI: 10.3390/biom14121630.


The Diagnosis and Prognosis Value of Circulating Exosomal lncRNA MALAT1 and LNC_000226 in Patients With Acute Myocardial Infarction: An Observational Study.

Gu X, Hou J, Weng R, Rao J, Liu S Immun Inflamm Dis. 2024; 12(12):e70088.

PMID: 39641229 PMC: 11621859. DOI: 10.1002/iid3.70088.


Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases.

Bernath-Nagy D, Kalinyaprak M, Giannitsis E, Abraham P, Leuschner F, Frey N Front Cardiovasc Med. 2024; 11:1425159.

PMID: 39314768 PMC: 11417624. DOI: 10.3389/fcvm.2024.1425159.


lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction.

Pan-Lizcano R, Nunez L, Pinon P, Aldama G, Flores X, Calvino-Santos R PLoS One. 2024; 19(5):e0304041.

PMID: 38771854 PMC: 11108170. DOI: 10.1371/journal.pone.0304041.


Nanoarchitectonics-based electrochemical aptasensors for highly efficient exosome detection.

Javed A, Kong N, Mathesh M, Duan W, Yang W Sci Technol Adv Mater. 2024; 25(1):2345041.

PMID: 38742153 PMC: 11089931. DOI: 10.1080/14686996.2024.2345041.


References
1.
Vausort M, Wagner D, Devaux Y . Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014; 115(7):668-77. DOI: 10.1161/CIRCRESAHA.115.303836. View

2.
Han P, Li W, Lin C, Yang J, Shang C, Nuernberg S . A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014; 514(7520):102-106. PMC: 4184960. DOI: 10.1038/nature13596. View

3.
Cheng J, Meng J, Zhu L, Peng Y . Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer. 2020; 19(1):66. PMC: 7098115. DOI: 10.1186/s12943-020-01189-3. View

4.
Su Y, Li L, Zhao S, Yue Y, Yang S . The long noncoding RNA expression profiles of paroxysmal atrial fibrillation identified by microarray analysis. Gene. 2017; 642:125-134. DOI: 10.1016/j.gene.2017.11.025. View

5.
Jia Y, Zheng W, Ye Z . Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer. Eur Rev Med Pharmacol Sci. 2020; 24(5):2358-2367. DOI: 10.26355/eurrev_202003_20503. View